Company Overview
Company Name
Unity Biotechnology
Address
285 E Grand Ave., South San Francisco, CA, 94080, United States
Website
unitybiotechnology.comPhone
(650) 416-1192Established
2014
About Unity Biotechnology
Unity Biotechnology is a United States-based company focused on developing new medicines to harness the biology of aging and address retinal diseases. The company's lead senolytic candidate, UBX1325, has shown promising results in a Phase 2 study for diabetic macular edema, demonstrating sustained and clinically meaningful improvements in vision.